Fidson Healthcare Plc, Nigeria’s leading pharmaceutical manufacturer, on Friday, 12 December 2025, held a signing ceremony at the Company’s Head Office in Lagos to initiate the formal launch of its highly anticipated Rights Issue upon receipt of the final regulatory approval of the Securities and Exchange Commission (SEC) and the Nigerian Exchange Limited (NGX).
This strategic capital raise aims to generate a gross sum of up to N21 billion – an injection vital to consolidating…
Read the full article here
